Drawing for CBD CELL BY DESIGN

USPTO serial 79272557

CBD CELL BY DESIGN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FRIEDMAN, LESLEE ANN
Law office
TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CBD CELL BY DESIGN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medical and veterinary preparations and articles; pharmaceutical preparations; diagnostic preparations and materials; live organs and tissues for surgical purpose; tissue-regenerative pharmaceutical preparations; pharmaceutical implants; biological implants; biological preparations for medical and veterinary purposes; biological tissue cultures for medical and veterinary purposes; stem cells; stem cells for medical and veterinary purposes; implants for guided tissue regeneration; biological implants comprised of living tissue or grown from stem cells for surgical purposes; stem cells for regenerative clinical, medical or pharmaceutical useACTIVE—
009Computer software; cloud computing software; computer software platforms; data buses; data processing software; data mining software; computer software to enable the searching of data; computer-aided measuring software; models for scientific experiments; process development platform software; artificial intelligence and machine learning software; sensory software; biosensors; bioreactors for cell culturing; bioreactors for research use; cell culture software for laboratory and medical use; incubators for cell cultureACTIVE—
042Scientific and technological services; research services; industrial analysis services; scientific research and development; scientific research and analysis; product research and development; analytical laboratory services; laboratory research, analysis and testing; scientific laboratory services; biomedical research services; research and development in the pharmaceutical and biotechnology fields; research and development in the field of therapeutics; biomedical research and screening; scientific services relating to the isolation and cultivation of human tissues and cells; engineering services; medical engineering; design services; design and development of medical devices; design and development of cell production processes; design and development of implants, human tissue and cells; scientific and technical data analysis; preparation of scientific reports; conducting of technical feasibility studies; testing and evaluation services; development of measuring, testing and analysis methods; research and development of new measuring and testing technology for others; material testing and analysis; product safety testing; scientific screening for cell culture; computer-aided measuring and non-destructive testing in the biomedical field; development of process systems for the biotechnology and biomedical industry; cloud computing services; platform as a service; software as a service; development of cloud-based process platforms; advice, consultancy and information relating to the aforesaid, included in this classACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 3, 2022FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 13, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 13, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 10, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 21, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 21, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 13, 2021MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 13, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 18, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 30, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 30, 2020RFRRREFUSAL PROCESSED BY MPU—
Aug 27, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 26, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 23, 2020DOCKASSIGNED TO EXAMINER—
Aug 23, 2020DOCKASSIGNED TO EXAMINER—
Dec 8, 2019DOCKASSIGNED TO EXAMINER—
Nov 30, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 21, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance